{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:07:51Z","timestamp":1791241671858,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ygyno.2013.07.093","type":"journal-article","created":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T10:01:54Z","timestamp":1374400914000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: Is there a case for thoracic cytoreduction?"],"prefix":"10.1016","volume":"131","author":[{"given":"Tamar","family":"Perri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Ben-Baruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Kalfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Beiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limor","family":"Helpman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat Ben-David","family":"Hogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Shapira-Frommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Korach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1098-2388(200007\/08)19:1<11::AID-SSU3>3.0.CO;2-3","article-title":"Current management of epithelial ovarian carcinoma: a review","volume":"19","author":"Marsden","year":"2000","journal-title":"Semin Surg Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.07.093_bb0010","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/gyno.2001.6328","article-title":"Identification of prognostic factors in advanced epithelial ovarian carcinoma","volume":"82","author":"Chi","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography\u2014a prospective study","volume":"108","author":"Risum","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.4396","article-title":"Effect of surgical debulking on survival in stage IV ovarian cancer","volume":"64","author":"Liu","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2013.07.093_bb0035","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.20920","article-title":"The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma","volume":"103","author":"Eitan","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0040","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1148\/radiol.10100162","article-title":"Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival","volume":"258","author":"Mironov","year":"2011","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ygyno.2013.07.093_bb0045","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1245\/s10434-009-0486-5","article-title":"Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery","volume":"16","author":"Lim","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2008.06.023","article-title":"Intra-thoracic cytoreduction of stage IV peritoneal malignancy: a case series","volume":"111","author":"Huang","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0055","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2006.10.010","article-title":"The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions","volume":"104","author":"Juretzka","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3802\/jgo.2010.21.2.75","article-title":"Maximal cytoreductive effort in epithelial ovarian cancer surgery","volume":"21","author":"Shih","year":"2010","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2001.6526","article-title":"Thoracoscopy for the management of advanced epithelial ovarian cancer\u2014a preliminary report","volume":"84","author":"Eisenkop","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"e-Suppl. 1","key":"10.1016\/j.ygyno.2013.07.093_bb0070","doi-asserted-by":"crossref","first-page":"e-S23","DOI":"10.3949\/ccjm.79.s2.05","article-title":"Video-assisted thoracoscopic surgery for the treatment of lung cancer","volume":"79","author":"Murthy","year":"2012","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers FIGO Committee on Gynecologic Oncology","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/gyno.1996.4540","article-title":"Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer","volume":"64","author":"Munkarah","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/gyno.2001.6172","article-title":"Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study","volume":"81","author":"Akahira","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.07.093_bb0100","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2013.07.093_bb0110","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies","volume":"16","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.01.010","article-title":"Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer","volume":"109","author":"Shah","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2013.07.093_bb0120","first-page":"1591","article-title":"New determinates of disease progression and outcome in metastatic ovarian carcinoma","volume":"25","author":"Davidson","year":"2010","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygyno.2007.10.022","article-title":"The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer","volume":"108","author":"Eisenhauer","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.07.093_bb0140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"Du Bois","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.093_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2008.09.010","article-title":"Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment","volume":"112","author":"Aletti","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.093_bb0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2004.04.027","article-title":"The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2012.05.018","article-title":"Video-assisted thoracic surgery (VATS) evaluation of intrathoracic disease in patients with FIGO III and IV stage ovarian cancer","volume":"126","author":"Klar","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.07.093_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2009.09.047","article-title":"Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients","volume":"116","author":"Diaz","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T09:54:31Z","timestamp":1596189271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813010135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090825813010135"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.093","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: Is there a case for thoracic cytoreduction?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}